Wave Banks $170m Upfront In GSK Oligonucleotide Deal, Analysts Back Shift To Partnership Model

Lucrative Potential Milestones

 
• By Ayisha Sharma
Woman holding up vial containing RNA strand
Wave's PRISM Platform Can Edit, Splice And Silence RNA • Source: Shutterstock

More from Business

More from Scrip